Company intelligence / Profile preview

NOCD

Chicago, Illinois, United Statestreatmyocd.com ↗

Ownership: Private
Employees: ~559
Development stage: Commercial

Overview

NOCD provides evidence-based virtual treatment for obsessive-compulsive disorder using ERP therapy. Peer-reviewed research has validated the effectiveness of their approach, with outcomes showing meaningful results twice as fast as standard ERP therapy. The company claims around 90% effectiveness among members and has built the world’s largest online community for people with OCD.

Therapeutic areas: Psychiatry
Modalities: Non-pharmacological therapyDevice (digital therapeutic/app-based)
Industry: Digital Health Medical Devices

Partnerships

Talkiatry – partnership to strengthen care journeys for individuals with OCD

Beyond the preview

Go deeper on NOCD.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NOCD.

Explore the full profile